Literature DB >> 29601147

Supervised physical exercise improves clinical, anthropometric and biochemical parameters in adult cystic fibrosis patients: A 2-year evaluation.

Ausilia Elce1, Ersilia Nigro2,3, Monica Gelzo4, Paola Iacotucci5, Vincenzo Carnovale5, Renato Liguori3, Viviana Izzo6, Gaetano Corso7, Giuseppe Castaldo3,4, Aurora Daniele3,8, Federica Zarrilli9.   

Abstract

OBJECTIVE: Cystic fibrosis (CF) is the most common inherited, life limiting condition among Caucasians. No healing therapy is currently available for patients with CF. The aim of the study was to define clinical, anthropometric and biochemical effects of regular, supervised physical exercise in a large cohort of patients with CF.
MATERIALS AND METHODS: Fifty-nine adult patients with CF that performed regularly supervised physical exercise in the last 3 years in comparison to 59 sex and age matched sedentary patients with CF were included in the study.
RESULTS: Physical exercise had significantly beneficial effects on: (a) FEV1% decline; (b) anthropometric parameters (lower number of cases with altered BMI, waist and arm circumferences); (c) lipid and glucose metabolism; (d) vitamin D serum levels. Of course, some of this improvement may be because of the better adherence to therapy typical of patients with CF that perform physical activity.
CONCLUSIONS: Such clinical and metabolic effects make supervised physical activity one of the hubs in managing patients with CF.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  anthropometric markers; biochemical markers; cystic fibrosis; physical exercise

Mesh:

Substances:

Year:  2018        PMID: 29601147     DOI: 10.1111/crj.12796

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

Review 1.  Physical activity and exercise training in cystic fibrosis.

Authors:  Thomas Radtke; Sherie Smith; Sarah J Nevitt; Helge Hebestreit; Susi Kriemler
Journal:  Cochrane Database Syst Rev       Date:  2022-08-09

2.  Physical Activity Regulates TNFα and IL-6 Expression to Counteract Inflammation in Cystic Fibrosis Patients.

Authors:  Ersilia Nigro; Rita Polito; Ausilia Elce; Giuseppe Signoriello; Paola Iacotucci; Vincenzo Carnovale; Monica Gelzo; Federica Zarrilli; Giuseppe Castaldo; Aurora Daniele
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

3.  Effects of Exercise on Nutritional Status in People with Cystic Fibrosis: A Systematic Review.

Authors:  William B Nicolson; Julianna Bailey; Najlaa Z Alotaibi; Stefanie Krick; John D Lowman
Journal:  Nutrients       Date:  2022-02-22       Impact factor: 5.717

4.  Adipocytokine profile in children with Kawasaki disease at a mean follow-up period of 5.5 years: A study from North India.

Authors:  Dibya Lochan Praharaj; Amit Rawat; Anju Gupta; Kanika Arora; Rakesh Kumar Pilania; Sagar Bhattad; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2022-07-09

5.  Association between phenotypic and genotypic characteristics and disease severity in individuals with cystic fibrosis.

Authors:  Gabriella Vieira Carneiro; Fabiana Sodré de Oliveira; Leandro Alves Pereira; Érica Rodrigues Mariano de Almeida Rezende; Luciana Carneiro Pereira Gonçalves; Vivian Mara Gonçalves de Oliveira Azevedo
Journal:  Rev Paul Pediatr       Date:  2022-09-09

6.  Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis.

Authors:  Rita Polito; Ersilia Nigro; Ausilia Elce; Maria Ludovica Monaco; Paola Iacotucci; Vincenzo Carnovale; Marika Comegna; Monica Gelzo; Federica Zarrilli; Gaetano Corso; Giuseppe Castaldo; Aurora Daniele
Journal:  Mediators Inflamm       Date:  2019-09-09       Impact factor: 4.711

Review 7.  Food, Nutrition, Physical Activity and Microbiota: Which Impact on Lung Cancer?

Authors:  Ersilia Nigro; Fabio Perrotta; Filippo Scialò; Vito D'Agnano; Marta Mallardo; Andrea Bianco; Aurora Daniele
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.